ucts Co., Pacific, MO ; rabbit anti-a,-PI IgG and anti-a2-macroglobulin IgG from Sigma Chemical Co., St. Louis, MO; prestained protein standards for SDS-PAGE from Bethesda Research Laboratories, Gaithersburg, MD; and all reagents for electrophoresis from Bio-Rad Laboratories, Richmond, CA. Sheep anti-HLE IgG was a gift of D. Burnett and R. Stockley, The General Hospital, Birmingham, England .
HLE-a,-PI Complexes. Reaction mixtures containing HLE and a,-PI (1 :1, mol/mol) were incubated at 37°C in a 10 mM phosphate buffer, pH 6 .8, for 15 min . The reaction was stopped either by addition of PMSF (<1 mM) or by injection onto an anionexchange column .
Electrophoresis. SDS-PAGE was performed according to the method of Laemmli (7) using 12% resolving gels on a Mini-slab apparatus from Idea Scientific (Corvallis, OR) . After electrophoresis the protein bands were stained for 15 min with 0.5% (vol/vol) Coomassie Blue R250 in acetic acid/isopropyl alcohol/water (1 :3 :6), destained with 50% methyl alcohol, and silver stained according to Wray et al. (8) .
Cells. Neutrophils were separated on Ficoll-Paque gradients from peripheral blood obtained from healthy volunteers (9) .
Chemotaxis . Chemotaxis was determined in modified Boyden chambers, as previously described (10, 11) . Briefly, 1 .2 X 106 neutrophils/ml were placed in the upper compartment and separated from chemoattractants in the lower compartment by a 2-Am pore size filter (Nucleopore Corp., Pleasanton, CA) overlaying a 0 .45-jm pore size filter (Millipore Corp., Bedford, MA) . After 1 h the chambers were disassembled and the membranes were stained with hematoxylin . Chemotaxis was quantified by counting at high dry magnification (X 400) the number of cells that migrated to the interface between the membranes (expressed as cells per high power grid). Five fields were counted for each experiment, and the results were corrected for the number of cells migrating in control chambers, which contained cells in the upper compartment and medium alone in the lower compartment . Experiments were performed in triplicate.
Purification of HLE-a,-PI Complexes. Chromatography was performed on a liquid chromatograph (model 1090; Hewlett-Packard Co., Palo Alto, CA) equipped with an HP1040 photodiode array detector . Elutions were monitored at 280 nm. Samples of HLE-a,-PI reaction mixtures were injected onto an AX-300 anion-exchange column (4 .6 X 250 mm) (Brownlee Labs, Santa Clara, CA) equilibrated with 5 mM Tris-HCI, pH 8.0 (solvent A), and developed with a gradient to 0 .8 M NaCI in solvent A (solvent B). The gradient was delivered at 0.5 ml/min, as follows: 0-5 min, 0% B; 5-10 min, 0-20% B; 10-20 min, 20-25% B; 20-25 min, 25% B; 25-65 min, 25-65% B . a,-PI Fragment . The M, 4,200 fragment of a,-PI was generated by hydrolysis of the Pro-357-Met-358 bond by mouse macrophage elastase and purified as described previously (6) .
Antibodies . Purified HLE-a,-PI complex (100 Al, 10 -6 M) was incubated with 14 A1 of stock anti-a,-PI IgG, 2 jl of anti-HLE IgG, or 24 J1 of anti-a2-macroglobulin IgG before use in a chemotactic assay. Controls were HLE-a,-PI complex incubated in assay medium alone and FMLP incubated in assay medium alone or with anti-a,-PI IgG. All incubations were at ambient temperature for 60 min .
Preexposure to Competitive Ligands. Neutrophils were incubated in 10 nM purified HLE-a,-PI complex or 10 nM purified M, 4,200 fragment of a,-PI for 30 min at ambient temperature, then washed three times with medium . The cells were then assayed for a chemotactic response to 1 nM HLE-a,-PI complex, 1 nM 4,200 fragment, or 10 nM FMLP.
Results
Equal molar amounts of HLE and human a,-PI were incubated together at 37°C for 15 min, resulting in the formation of a stable HLE-a,-PI inhibitory complex . Dilutions of this reaction mixture were assayed for their ability to stimulate migration of human neutrophils in modified Boyden chambers. Migration Stimulation of neutrophil chemotaxis by reaction mixtures containing HLE-a,-PI complexes. a,-PI was incubated for 15 min with HLE, 1 :1 mol/mol ("); HLE, 1 :0 .25 mol/mol (A); or HLE (1 :1 mol/mol) that had been inactivated with PMSF before incubation (0). Dilutions of the reaction mixtures were then assayed for their ability to stimulate chemotaxis of human neutrophils. The points represent the average of triplicate determinations, and the error bars represent the standard error of the mean . h.p .g ., high power grid . Migration stimulated by 10 -" M FM LP (the positive control) was 153 ± 4.2 cells.
was equivalent to that stimulated by 10 nM FMLP (the positive control) . Maximal stimulation of migration was achieved at a dilution equivalent to 1 nM a,-PI initially added to the reaction mixture (Fig. 1) . Chemotaxis was reduced when the proportion of HLE in the reaction mixture was reduced four-fold, suggesting that the chemotactic activity was proportional to the HLE-a,-PI complex in the reaction mixture. Neither native a,-PI nor HLE alone stimulated migration of neutrophils .
In our previous study (6), proteolytically modified a,-PI was shown to be chemotactic for neutrophils. In that study the metalloproteinase macrophage elastase was used to degrade a,-PI because it would not form an inhibitory complex (4, 5) . In the present study, a stable inhibitory complex was formed between FtcURE 2. Purification of HLE-a l -PI complex. a,-PI was incubated with an excess of HLE, then applied to an AX-300 anion-exchange column equilibrated with 5 mM Tris-HCA, pH 8.0 . Absorbance was monitored at 280 run and expressed as milliabsorbance units (mAU).
The column was developed with a gradient of NaCl as described in Materials and Methods.
(Inset) Silver-stained SDS-polyacrylamide electrophoretic gel containing native a,-PI (M, HL.E-a)-PI reaction mixture (R), and an aliquot of a fraction corresponding to peak C containing HLE-a,-PI complex (C). Molecular weight markers (M, X 10 -') are shown at the left . HLE and a,-PI . When HLE and a,-PI were incubated under conditions of excess HLE, proteolytically modified complex and a,-PI were detected in addition to the classical inhibitory complex . To determine if the inhibitory complex itself stimulated migration, the complex was purified. Equal molar amounts of FILE and a,-PI were incubated together to form the inhibitory complex. The reaction mixture was then fractionated on an AX-300 anion-exchange column, and peak fractions were analyzed by electrophoresis . The HLE-a,-PI complex eluted as a single band with an apparent M, of 80,300 (Fig. 2) . Various concentrations of the purified complex were assayed for their ability to stimulate migration of neutrophils . Again, migration was equivalent to that stimulated by the FMLP positive control (Fig. 3) . The optimal concentration of purified HLE-al-PI complex was 1 nM, the same concentration that stimulated maximal migration when the crude reaction mixture was used (Fig. 1) .
To distinguish chemotactic migration from chemokinetic migration, various concentrations of purified HLE-al -PI complex were placed in the upper and lower compartments of modified Boyden chambers during the migration assay . A "checkerboard" analysis verified that HLE-al-PI complex stimulated chemotaxis, because cells migrated only when there was a concentration gradient (Table I) . Because the HLE-a,-PI complex contains elastase as well as a,-PI, it was possible that the chemotactic signal was associated with the elastase portion of the complex . To test this possibility, purified HLE-a,-PI complex was separately incubated with anti-a,-PI, anti-HLE, and anti-a2-macroglobulin antibodies before use in the migration assay . The antibody against a,-PI inhibited chemotaxis, whereas antibody against HLE did not (Fig . 4) . Therefore, the chemotactic signal was associated with a,-PI and not the elastase portion of the complex . The lack of inhibition by anti-a2-macroglobulin antibody (data not shown) demonstrated that the inhibition of chemotaxis by anti-a,-PI antibody was not due to nonspecific protein binding. Moreover, because antibody to a,-PI did not inhibit chemotaxis stimulated by FMLP, it was evident that inclusion of anti-a,-PI antibody in the reaction mixture did not generally interfere with the ability of neutrophils to migrate .
The chemotactic activity of proteolytically inactivated a,-PI resides in the M, 4,200 fragment (6), which is the result of hydrolysis of the Pro-357-Met-358 peptide bond (5) . When HLE forms an inhibitory complex with a,-PI, the Met-358-Ser-359 bond is broken, resulting in a similar fragment. In both cases the cleavage fragment is not released as a free molecule but remains associated with the remainder of the a,-PI molecule in a rearranged position (6, 12) . To deter-FIGURE 5. Neutrophil chemotaxis before and after exposure to competitive ligands. Neutrophils were incubated for 30 min at ambient temperature with 10 nM purified HLE-a,-PI complex (light striped bars), 10 nM purified M, 4,200 fragment of a,-PI (dark striped bars), or assay medium alone (solid bars), then washed three times with assay medium . The cells were then assayed for a chemotactic response to 1 nM HLE-a,-PI complex, 1 nM 4,200 fragment, or 10 nM FMLP . The data represent an average of triplicate determinations, and the error bars represent the standard error of the mean . mine if the source of the activity of the HLE-a,-PI inhibitory complex could be localized to the region of the 4,200 fragment, the following experiments were carried out . Neutrophils were incubated with 10 nM 4,200 fragment isolated from proteolytically inactivated a,-PI and then washed free of unbound fragment before they were tested for their chemotactic response to 1 nM HLE-a,-PI complex . This pretreatment eliminated chemotaxis (Fig. 5) . Similarly, when neutrophils were preincubated with 10 nM HLE-a,-PI complex, migration toward 1 nM 4,200 fragment was eliminated. Therefore, the source of the chemotactic activity of the HLE-a,-PI complex was the same as that of the 4,200 fragment. Preincubation with either 4,200 fragment or HLE-a,-PI complex had no effect on migration toward 10 nM FMLP, indicating that the preincubations did not produce a generalized decrease in the chemotactic responses of these cells .
Discussion
The function of a,-PI is usually considered solely in light of its ability to inactivate serine proteinases, especially HLE. The present study suggests that a consequence of a,-PI-mediated inhibition of HLE is the generation of a chemotactic signal for neutrophils . The inhibitory complex therefore becomes an inflammatory mediator. This newly described characteristic of a,-PI is not limited to proteinase-inhibitor complexes, because proteolytically inactivated a,-PI also seems to act as an inflammatory mediator by a similar mechanism (6) . The data suggest that an identical site with chemotactic potential is exposed in both HLE-a,-PI complex and a,-PI proteolytically inactivated by hydrolysis of the Pro-357-Met-358 bond.
The local regulation of a,-PI-mediated chemotaxis may be quite complicated . a,-PI from the circulation may diffuse into tissue and form inhibitory complexes or become proteolytically inactivated . In addition, a,-PI may be made locally by human monocytes (13) and macrophages (14) . It is unclear whether human monocytes or macrophages secrete metalloproteinases that could proteolytically inactivate a,-PI . However, neutrophil collagenase can proteolytically inactivate a,-PI (15) . Human monocytes have been reported to produce a serine elastase similar to FILE (16) and may generate HLE-a,-PI complexes (14) . Therefore, local production of a,-PI, HLE, and eel -PI-degrading proteinases may initiate or alter the inflammatory response .
Evidence presented in this study suggests that a single neutrophil surface receptor binds both proteolytically inactivated a,-PI and the a,-PI in the inhibitory complex . The site responsible for recognition appears to reside in a domain carboxyl to the Met-358-Ser-359 peptide bond; exposure of this area is probably the result of the severe rearrangement of modified a,-PI (12) . Saturation of the receptor by preincubation with HLE-a,-PI complex prevents further chemotaxis toward modified a,-PI but does not interfere with chemotaxis toward an unrelated molecule, FMLP. Therefore, this as yet uncharacterized receptor must be different from the FMLP receptor. Whether it is a receptor for other known neutrophil chemotactic stimulants, such as C5a or LTB4, remains to be determined .
Little is known about the fate of HLE-a,-PI complexes . a2-Macroglobulin-
